- Boron Compounds
- Accession Number
Inorganic or organic compounds that contain boron as an integral part of the molecule.
Drug Drug Description Bortezomib A proteasome inhibitor used to treat multiple myeloma in patients who have not been successfully treated with at least two previous therapies. Phenylethane Boronic Acid Not Available 3-Nitrophenylboronic Acid Not Available AN0128 Investigated for use/treatment in acne, atopic dermatitis, pediatric indications, and psoriasis and psoriatic disorders. Flovagatran Investigated for use/treatment in thrombosis. Talabostat Investigated for use/treatment in lymphoma (non-hodgkin's), leukemia (lymphoid), lung cancer, melanoma, and pancreatic cancer. Boric acid No FDA- or EMA-approved therapeutic indications on its own. Delanzomib Delanzomib has been used in trials studying the treatment of Solid Tumors, Multiple Myeloma, and Lymphoma, Non-Hodgkin. Vaborbactam A beta lactamase inhibitor used to treat complicated urinary tract infections. Perboric acid In the industry, sodium perborate is used as a disinfectant. It is also part of the ingredients for detergents, bleach powders, and personal care formulations. In cosmetic products, perboric acid... Sodium borate No FDA- or EMA-approved therapeutic indications on its own. Borate ion Not Annotated Dutogliptin Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II. Phenylboronic acid Not Available
- Drugs & Drug Targets